FDA Approves Xdemvy
![FDA Approves Xdemvy: Breakthrough for Eyelid Disease](https://pharmtales.com/wp-content/uploads/2023/07/Tarsus-Xdemvy-is-approved-by-the-FDA-as-the-first-therapy-for-common-eyelid-illness.jpg)
Tarsus’ Xdemvy is approved by the FDA as the first therapy for common eyelid illness
SG Tylor
Source – Tarsus Pharmaceuticals Tarsus Pharmaceuticals has achieved a groundbreaking milestone with the FDA approval of Xdemvy, the first-ever treatment ...